Mechanistic themes seen in preclinical research In animal and mechanistic work, AOD-9604 has been associated with: Increased lipolysis (breaking down stored fat) Reduced lipogenesis (reducing fat storage) Interactions with -adrenergic pathways in adipose tissue have been discussed as part of its lipolytic signaling profile (OUP Academic) In obese animal models, AOD-9604 has shown reductions in body weight and body fat and changes consistent with increased fat mobilization
When it crosses the blood-brain barrier and binds to c-Met, it initiates synaptogenesis: new dendritic spines form, synaptic connections strengthen, and neurons that were alive but under-connected begin to integrate more fully into functional networks
Search online for weight loss specialists or bariatric care physicians
Medications: Long-term use of acid-reducing drugs (like PPIs) or metformin (for diabetes) can interfere with B12 absorption
(Front Pharmacol, 2018) conducted a 6-month safety study with injectable BPC-157, finding no significant changes in liver function, kidney parameters, or hematologic markers
